2,3-dinor-thromboxane b2 has been researched along with Left Ventricular Outflow Obstruction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adatia, I; Barrow, SE; Haworth, SG; Ritter, JM; Stratton, P | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Left Ventricular Outflow Obstruction
| Article | Year |
|---|---|
Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Infant; Male; Thromboxane A2; Thromboxane B2; Ventricular Outflow Obstruction | 1993 |